Purpose Thoracic fat has been associated with an increased risk of coronary artery disease (CAD). As endotheliumdependent vasoreactivity is a surrogate of cardiovascular events and is impaired early in atherosclerosis, we aimed at assessing the possible relationship between thoracic fat volume (TFV) and endothelium-dependent coronary vasomotion. Methods Fifty healthy volunteers without known CAD or major cardiovascular risk factors (CRFs) prospectively underwent a 82 Rb cardiac PET/CT to quantify myocardial blood flow (MBF) at rest, and MBF response to cold pressor testing (CPT-MBF) and adenosine (i.e., stress-MBF). TFV was measured by a 2D volumetric CT method and common laboratory blood tests (glucose and insulin levels, HOMA-IR, cholesterol, triglyceride, hsCRP) were performed. Relationships between CPT-MBF, TFV and other CRFs were assessed using non-parametric Spearman rank correlation testing and multivariate linear regression analysis. Results All of the 50 participants (58±10y) had normal stress-MBF (2.7±0.6 mL/min/g; 95 % CI: 2.6-2.9) and myocardial flow reserve (2.8±0.8; 95 % CI: 2.6-3.0) excluding underlying CAD. Univariate analysis revealed a significant inverse relation between absolute CPT-MBF and sex (ρ=-0.47, p= 0.0006), triglyceride (ρ=-0.32, p=0.024) and insulin levels (ρ=-0.43, p=0.0024), HOMA-IR (ρ=-0.39, p=0.007), BMI (ρ=-0.51, p=0.0002) and TFV (ρ=-0.52, p=0.0001). MBF response to adenosine was also correlated with TFV (ρ=-0.32, p=0.026). On multivariate analysis, TFV emerged as the only significant predictor of MBF response to CPT (p= 0.014). Conclusions TFV is significantly correlated with endothelium-dependent and -independent coronary vasomotion. High TF burden might negatively influence MBF response to CPT and to adenosine stress, even in persons without CAD, suggesting a link between thoracic fat and future cardiovascular events.
Introduction
Endothelial dysfunction is widely recognized as the key-step toward atherosclerosis and as a surrogate predictor of a cardiovascular event. Numerous studies have highlighted the influence of diabetes, insulin resistance, uncontrolled hypertension, smocking as well as menopause upon the impairment of endotheliumdependent vasomotion using quantitative cardiac positron emission tomography-computed tomography (PET/CT) analysis.
Thoracic fat is defined by the sum of intra-pericardial fat derived from splanchnopleuric mesoderm plus extrapericardial fat surrounding the pericardium within the mediastinum [1] . Recent studies reported that pericardial fat correlated with coronary plaque [2] and might promote coronary artery disease (CAD) development by influencing microvascular function [3] . In fact, although pericardial fat has been Thoracic fat volume is independently associated with coronary vasomotion independently associated with an increased risk of CAD [4] [5] [6] , the exact mechanism is not known yet. Some studies suggest a direct influence of adipokines by an outside-toinside pathway from epicardial fat, contributing to vascular inflammation and plaque progression. Two recent studies showed an association between intra-pericardial fat and hyperemic coronary blood flow measured by PET/CT [7] and between epicardial fat thickness measured by echocardiography and flow-mediated dilation [8] . Nevertheless, no relation between endothelium-dependent coronary vasoreactivity and thoracic fat has been demonstrated yet.
Our aim was to assess whether thoracic fat, at an early stage, may influence endothelium-dependent vasomotion in patients without CAD or detectable cardiovascular risk factors.
Methods

Study design
In this monocentric study, volunteers were prospectively enrolled from January 2009 to June 2009. Before inclusion, they all underwent a medical examination to screen for cardiovascular risk factors. Inclusion criteria were (1) volunteers with no cardiovascular risk factors and (2) no medication. Participants with diabetes mellitus (fasting plasma glucose level >7.0 mmol/L), past or present smoking, hypertension (≥140/ 90 mmHg), low-density lipoprotein (LDL) level ≥4.1 mmol/ L, high-density lipoprotein (HDL) level <0.8 mmol/L, triglyceride (TG) level >4.5 mmol/L, peripheral artery disease, known CAD or myocardial infarction, cardiomyopathy, renal failure, peripheral neuropathy, systemic disease, or contraindication to adenosine (asthma, chronic obstructive bronchitis, 2nd and 3rd degree atria-ventricular block) were thus excluded. Weight was not an exclusion criterion.
For every participant, fasting glucose plasma, insulin plasma, LDL, HDL, TG, high-sensitivity C-reactive protein (hsCRP) levels were measured, and insulin resistance was assessed by the calculating homeostasis model assessmentinsulin resistance (HOMA-IR) index (HOMA-IR = fasting plasma glucose (mmol/L)×fasting plasma insulin (pmol/L) / 162). Volunteers were refrained from eating any food at least 6 h and from caffeine intake ≥24 h before the PET studies. The study was approved by the ethics committee of The University of Lausanne. Every participant signed a written consent form.
PET studies
All the volunteers fulfilling the inclusion criteria (n=50) underwent 82 Rb cardiac PET/CT measurements of myocardial blood flow (MBF). After a rest study, participants underwent cold pressor testing (CPT) to assess MBF changes mainly due to endothelium-dependent vasomotion [9] . CPT was performed by a 2-min immersion of the left lower limb in iced water starting one minute before the administration of 82 Rb. Finally, pharmacological stress was carried out by adenosine (140 μg/kg/min) infusion over 6 minutes to determine myocardial blood flow increase (i.e., stress-MBF) mainly due to endothelium-independent vasomotion and myocardial flow reserve (MFR) in order to exclude underlying CAD. For each study, after a 10-second infusion of 82 Rb (1450 MBq), 6-min dynamic (12x8 s, 5x12 s, 1x30 s, 1x60 s, 1x120 s) cardiac PET (Discovery LS, GE Medical Systems, Milwaukee, WI, USA) was acquired. A cardiac computed tomography (CT) was also performed to correct for photon attenuation by soft tissues.
Data were reconstructed using the ordered subset expectation maximization (OSEM; 8 subsets, 2 iterations) method and processed with the fully-automatic Flowquant 1.2.3 software using a previously described [10] , two-compartment modeling approach to derive MBF at rest, during the cold pressor test and during the pharmacological stress. Stress/ rest uptake images were also analyzed in a semi-quantitative way (summed rest score and summed difference score) to exclude myocardial ischemia/scar using a 17-segment model. Before processing, good alignment between the PET and CT series was verified to avoid attenuation correction artifact.
Blood pressure, heart rate and a 12-lead electrocardiogram (ECG) were recorded at 1-minute intervals during each procedure. To correct for cardiac workload, rest and CPT MBF were also normalized using the rate-pressure product (RPP= heart rate×systolic blood pressure).
The radiation dose for each patients was estimated to be 3× 1.8 mSv for rest, CPT and stress Rb-82 [11] , and 3×0.2 mSv for the low-dose attenuation correction CT [12] , resulting in a total dose of 6 mSv. The product of the CT dose index (CTDI=0.7±0.1 mGy) and the z-axis scan coverage (18 cm) provides the dose-length product (DLP=12.6±1.7 mGy.cm), which was subsequently multiplied by the conversion factor for the chest (k=0.017 mSv. mGy -1 .cm -1 ) to obtain the effective dose for the CT acquisitions.
Thoracic fat volume quantification
CT studies were performed using an unenhanced, low-dose protocol (120-kV tube voltage, 10-mA tube current, 1.0 sec/ rotation, 4×5-mm detector configuration, 50-cm scan field-ofview, 18-cm z-axis coverage) on the 4-slice CT scanner (Light Speed Plus, GE Medical Systems, Milwaukee, WI, USA) of our PET/CT (Discovery LS; GE Medical Systems, Milwaukee, WI, USA). Data were reconstructed by filtered back projection with a 512×512-pixel matrix and slice thickness of 5 mm resulting in a spatial resolution of 1×1×5 mm. Thoracic fat volume (TFV) was determined using a threshold twodimensional (2D) short axis-based method after transferring patient imaging data on a dedicated workstation (Advantage Windows 4.4; GE Medical Systems, Milwaukee, WI, USA) [13] . Reformatted images were obtained from the raw data of axial images to the 2D short axis views with a 5-mm slice thickness and 5-mm intersection gaps. TFV was defined as the adipose tissue from the surface of the heart to the adjacent organ into the inferior mediastinum. Thus, in a volume of interest extending from the pulmonary trunk bifurcation to the diaphragm, a CT attenuation threshold (-200 to -30 HU) was used to isolate thoracic fat. Finally, TFV in mL was automatically measured using a histogram-based analysis (figure 1).
Statistical analysis
All statistical analyses were carried out with Stata 11.1. Continuous variables are presented as the mean ± standard deviation (SD). Wilcoxon rank sum testing was used to compare characteristics according to sex (male=1, female=0). Relations between variables were assessed using a non-parametric Spearman's rank correlation test (ρ). For sex, significance or non-significance of the relations was confirmed using logistic regression that is more suitable for categorical variables (data not shown). Multivariate linear regression analysis and stepwise multiple linear regression analysis were performed using significant univariate predictors to determine independent relationship to TFV or MBF response. Before performing multivariate analysis, collinearity of variables was searched. A threshold of >0.7 for the absolute correlation coefficient was considered to remove collinear variables [14] . Weight was thus judged collinear to sex and body-mass index (BMI), and insulin/glucose w e r e j u d g e d c o l l i n e a r t o h o m e o s t a s i s m o d e l assessment-insulin resistance (HOMA-IR). Consequently, only sex, BMI and HOMA-IR were included in the multivariate analysis model. A p-value <0.05 was considered statistically significant.
Results
Population characteristics
In total, 50 volunteers (19 F/31 M) were included. All of them successfully underwent complete PET/CT studies and laboratory blood tests. There were no unexpected side effects during adenosine infusion. All the patients had a normal stress/rest perfusion study with a summed difference score and a summed rest score of zero. Baseline characteristics are summarized in Table 1 . There was a significant difference between men and women for weight, BMI, insulin, glucose, HDL, LDL levels, but not for hsCRP and TG (data not shown).
Among baseline characteristics, fasting insulin levels were highly correlated with sex (ρ=0.45, p=0.0012), weight (ρ= 0.79, p<0.0001), BMI (ρ=0.82, p<0.0001), plasma glucose levels (ρ=0.62, p<0.0001), hsCRP (ρ=0.60, p<0.0001) and HDL (ρ=-0.57, p<0.0001). On multivariate linear regression analysis (sex, BMI, glucose, hsCRP and HDL levels), BMI, glucose and hsCRP emerged as independently related to fasting insulin levels (p<0.03).
TFV
All of the 50 CT series were successfully processed. Mean TFV was 250±156 mL. Men had a significantly higher TFV than women (317±154 vs. 141±83 mL, p<0.0001). Among clinical and biological characteristics, shown in Table 2 , TFV was significantly correlated with sex (ρ=0.59, p<0.0001), weight (ρ=0.84, p<0.0001), BMI (ρ=0.85, p<0.0001), insulin levels (ρ=0.68, p<0.0001), glucose plasma levels (ρ= 0.52, p = 0.0002), HOMA-IR (ρ =0.67, p < 0.0001), HDL levels (ρ=-0.61, p<0.0001), TG levels (ρ=0.53, p=0.0001) and hsCRP (ρ=0.41, p=0.005). Relationships between TFV and age or LDL level were not statistically significant (p>0.4). Including variables significantly correlated with TFV in univariate analysis (sex, BMI, HOMA-IR, HDL, TG and hsCRP), multiple linear regression analysis highlighted that sex (p=0.005) and BMI (p<0.001) were independently correlated with TFV.
Myocardial blood flow response
Fifty participants significantly increased MBF from baseline conditions (rest-MBF=1.0±0.4 mL/min/g) in response to pharmacological stress (stress-MBF =2.7 ± 0.6 mL/min/g, p<0.0001). For all of them, myocardial flow reserve was >2 and stress-MBF was>2 mL/min/g, excluding hemodynamically significant CAD, balanced ischaemia or microvascular disease. Using a non-parametric Spearman's rank correlation test, MBF response to adenosine was only associated with weight (ρ=-0.31, p=0.029) and TFV (ρ=-0.32, p=0.026). TFV was the only variable independently associated with MBF response to adenosine on stepwise multiple linear regression analysis (p=0.012).
Rate pressure product (RPP) significantly increased by 28 ±3 % during CPT compared to rest conditions (10,433± 2792 mmHg.min -1 vs. 8137 ± 1885 mmHg.min -1 , p<0.0001). Myocardial blood flow significantly increased from 1.0±0.4 mL/min/g to 1.2±0.3 mL/min/g (p=0.01) in response to CPT. Furthermore, absolute CPT-MBF was significantly correlated (Table 3) with sex (ρ=-0.47, p=0.0006), weight (ρ=-0.58, p<0.0001), BMI (ρ=-0.51, p=0.0002TG level (ρ=-0.32, p=0.024), fasting blood insulin (ρ=-0.43, p= 0.0024), HOMA-IR (ρ=-0.39, p=0.007) and TFV (ρ=-0.52, p=0.0001) (figure 2). On stepwise multiple linear regression analysis, after exclusion of weight and fasting blood insuline, TFV emerged as the only independent predictor of MBF response to CPT (β=-0.38, p=0.014).
Discussion
To our knowledge, this is the first study reporting a direct and independent correlation between TFV and endotheliumdependent coronary vasomotion in patients without previously known cardiovascular risk factors, medication or significant biological risk factors.
TFV relation to baseline characteristics
TFV has recently been related to cardiovascular risk [4] . Whilst global fat burden is well known to be involved in the development of metabolic syndrome, there is increasing evidence that thoracic fat independently contributes to CAD genesis due to its function as well as its anatomical position. In accordance with a previously published study [15] , we found a strong correlation between weight and TFV (ρ = 0.84, p < 0.0001) as well as between BMI and TFV (ρ = 0.85, p<0.0001). Moreover, BMI was independently correlated with TFV (p<0.001), hence confirming the underlying relation between global fat burden and thoracic fat. As is the case with other white adipose tissue, it was reported that thoracic fat acts as an independent endocrine organ, secreting hormones such as adiponectin, leptin, or resistin [16] . By secreting adipokines, adipose tissue may promote insulin plasma production and insulin resistance [17] . Supporting this hypothesis, our analysis highlighted the correlation between insulin plasma levels (ρ=0.68, p<0.0001), HOMA-IR (ρ=0.67, p<0.0001) and TFV. Insulin resistance, hence, results in increased releasings of TG in the peripheral circulation due to adipocyte lipolysis, as the relation between TFVand TG levels might suggest (ρ=0.53, p=0.0001). Thoracic fat may also promote systemic inflammation by local macrophages secreting cytokines and chemokines such as hsCRP [16] . This is supported by the correlation between hsCRP and TFV (ρ= 0.41, p=0.005). Thus, by contributing early to chronic systemic inflammation that has extensively been reported as a key-step toward atherosclerosis [18, 19] , thoracic fat may act in the development of CAD. 
Thoracic fat relation to endothelium-dependent vasomotion
Endothelial function as well as MBF has extensively been studied using cardiac PET/CT for the past few years. Endothelium-dependent vasoreactivity is a surrogate marker of cardiovascular events [20] , and can be significantly impaired by smoking, uncontrolled diabetes or hypertension, dyslipidemia, or menopause. Therefore, numerous studies demonstrated the need for a control of cardiovascular risk factors to normalize response to CPT as a sign of conserved endothelium-dependent vasomotion [21] [22] [23] [24] [25] . In accordance with those results, we report a significant inverse correlation between MBF response to CPT and TG levels (ρ=-0.32, p= 0.024), fasting insulin plasma levels (ρ=-0.43, p=0.0024) or HOMA-IR (ρ=-0.39, p=0.007), even in a population of healthy volunteers. As reported above, numerous studies demonstrated that adiponectin plasma levels were negatively correlated with visceral fat burden and that low adiponectin contributed to insulin resistance [17, 26] . Prior et al. [27] showed that insulin resistance had a direct negative influence upon endothelium-dependent vasoreactivity. Thus, our results suggest that an increased TFV may be related to insulin resistance and impaired endothelial response to CPT, potentially by reducing adiponectin plasma levels. This point needs confirmatory studies, however.
Although we did not find any correlation between hsCRP and CPT-MBF, the relation between TFV and hsCRP (ρ= 
Abbreviations: BMI=body mass index; CPT=cold pressor test; HDL= high-density lipoprotein; HOMA-IR=homeostasis model assessmentinsulin resistance; hsCRP=high-sensitivity C-reactive protein; IQR=in-terquartile range; LDL=low-density lipoprotein; MBF=myocardial blood flow; MFR=myocardial flow reserve; TFV=thoracic fat volume; SD=standard deviation; TG=triglyceride.
* Although significant at the univariate level, these variables have not been included in the multivariate analysis because of collinearity (between weight and BMI, as well as between insulin, glucose and HOMA-IR). 0.41, p=0.005) suggest that thoracic fat may contribute to chronic systemic inflammation, which results in an impairment of basal endothelial NO synthesis [18] . The indirect effect of thoracic fat upon endothelium could be mediated by an increased insulin resistance and a pro-inflammatory cytokine production. Although a direct vasocrine outside-toinside effect of some adipokines from perivascular fat has been reported in a swine model [28] , we cannot confirm its reality in humans based on our study. The independent correlation between TFV and CPT-MBF (p=0.014) found on multivariate analysis may suggest that TFV could participate in those different pathways that lead to significantly impaired coronary endothelial function. However, the respective role of epicardial and paracardial fat in this process cannot be deduced from our study.
Thoracic fat relation to endothelium-independent vasomotion
Bucci et al. [7] recently reported that both intra-pericardial fat and extra-pericardial fat were significantly associated with hyperemic MBF (R = -0.36 and R = -0.44, respectively; p<0.0005). Supporting the direct influence of TFV upon endothelium-independent vasomotion, we found a negative correlation between TFV and hyperemic MBF (ρ=-0.32, p= 0.026). Bucci et al. [7] concluded that the independent predictive value of intra-pericardial fat volume upon hyperemic MBF supports the hypothesis of an outside-to-inside direct paracrine/vasocrine effect. It has also been reported that perivascular fat could stimulate smooth muscle cell proliferation [29] . Though we were not able to discriminate respective contribution of epicardial and paracardial fat, our data suggest that thoracic fat could contribute early to atherosclerosis by impairing endothelial function and modifying smooth vessel musculature reactivity. Moreover, a direct effect of thoracic fat upon the coronary wall from the intima to the adventice could contribute to the formation of arterial plaque, and promote plaque inflammation, as recently suggested by Saam et al. [30] . From endothelial dysfunction to CAD, mounting evidences, thus, suggest that thoracic fat is a crucial actor of coronary atherosclerosis due to his proinflammatory and vasoactive role.
Study limitations
Although our study demonstrated an independent correlation between TFV and MBF response to CPT as well as between TFV and MBF response to adenosine, we recognize some limitations.
Our volunteers had no cardiovascular risk factors, and although everyone had thoracic fat, it was not possible to use a normal control population for comparison. Nevertheless, a prospective study assessing the evolution of TFV and CPT-MBF could be planned to support the results we showed by taking the subject as his/her own control. The exact effect of adipokine upon endothelium-dependent vasomotion could also be specified by prospectively measuring adipokine plasma changes over time.
Moreover, because both intra-pericardial fat and extrapericardial fat have different embryologic origin, they may have different contributions to atherosclerosis process. Due to ungated acquisition and low-dose parameters of CT acquisition, image spatial resolution was not sufficient to separately measure epicardial (or intra-pericardial) and paracardial (or extra-pericardial) fat volume, and, hence, its relation to CPT-MBF. Nevertheless, it may be difficult to distinguish their exact influence, since both can contribute to systemic inflammation and insulin resistance, leading to impairment of baseline endothelial function. To avoid misinterpreting the nature of our data, we, therefore, strictely compared our results to previous studies that used the same definition for thoracic fat or that reported results applicable to both epicardial and paracardial fat. As spatial resolution was different from Cheng et al. [1] , a comparison with previously published normal TFV values was not possible.
Finally, as TFV could easily be quantified, it could be easily implemented in daily practice. While endotheliumdependent coronary vasomotion is a surrogate of future cardiovascular events, the prognostic value of TFV as compared to CPT-MBF remains unknown. The clinical relevance of initial TFV quantification should, therefore, be investigated, especially in patients with low likelihood of developing a cardiovascular event, as well as the impact of TFV decrease on Thoracic Fat Volume (mL) Fig. 2 Relationship between myocardial blood flow response to cold pressor testing and thoracic fat volume. CPT = cold pressor test; MBF = myocardial blood flow cardiac event occurrence. TFV monitoring could, thus, constitute an attractive complementary tool to assess a patient's cardiovascular risk.
Conclusions
TFV significantly correlated with both endotheliumdependent and endothelium-independent coronary vasomotion, even in persons with normal hyperemic myocardial perfusion imaging. Since endothelium-dependent vasomotion has been recognized as a surrogate marker for cardiovascular events, our results suggest the involvement of thoracic fat in future cardiovascular events. While outside-toinside adipokine secretion through the arterial wall has been described, our results might suggest an effect upon NOdependent and NO-independent vasodilatation, as well as the influence of insulin resistance and chronic systemic inflammation mediated by thoracic fat. Further studies are needed to elucidate the putative mechanism.
